Madeleine Puissant
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage (BADCATS) (NCT06569212) | Madeleine Puissant | 2024-09-23 |
Track Madeleine Puissant automatically
Every clearance here is in the API, with alerts when new ones post.